1. Home
  2. LXRX
  3. LXRX News

Latest Lexicon Pharmaceuticals Inc. (LXRX) News on September 12, 2025

Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

GlobeNewswire

4 days ago

Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

Associated Press Finance

4 months ago

Lexicon: Q1 Earnings Snapshot

MT Newswires

5 months ago

Top Midday Gainers

Associated Press Finance

6 months ago

Lexicon: Q4 Earnings Snapshot

MT Newswires

10 months ago

Sector Update: Health Care

Associated Press Finance

10 months ago

Lexicon: Q3 Earnings Snapshot

MT Newswires

10 months ago

Top Midday Decliners

MT Newswires

10 months ago

Top Premarket Decliners

Share on Social Networks: